Temedica raised €17M in a Series B round in Jan 2020. The company is based in Munich, Germany. Investors in the round: MIG Fonds, Santo Venture Capital. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €17M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
